Key terms
About KTTA
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KTTA news
Feb 15
2:40pm ET
Pasithea Therapeutics Corp trading resumes
Feb 15
2:35pm ET
Pasithea Therapeutics Corp trading halted, volatility trading pause
Jan 08
8:08am ET
Pasithea Therapeutics announces invention of crystalline form of PAS-004
Jan 02
8:35am ET
Pasithea Therapeutics announces FDA acceptance of IND application for PAS-004
Dec 29
7:50pm ET
Pasithea Therapeutics Corp trading halted, news pending
Dec 11
8:32am ET
Pasithea Therapeutics announces in vivo preclinical efficacy data for PAS-004
Nov 29
8:02am ET
Pasithea Therapeutics announces outcome of pre-IND meeting for PAS-004
No recent press releases are available for KTTA
KTTA Financials
Key terms
Ad Feedback
KTTA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KTTA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
